BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma
Authors:
- Peng LinPLPeng Lin
Open Access
- 30 July 2025
- journal article
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (8) , 102258
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Medical Sciences and Peking Union Medical College
- National Natural Science Foundation of China
This publication has 70 references indexed in Scilit:
- Ultrafast one‐pass FASTQ data preprocessing, quality control, and deduplication using fastpiMeta, 2023
- ISG20: an enigmatic antiviral RNase targeting multiple virusesFEBS Open Bio, 2022
- Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistancePharmacological Research, 2021
- Integrated analysis of multimodal single-cell dataCell, 2021
- A Genome-wide CRISPR Screen Reveals a Role for the Non-canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell FunctionImmunity, 2020
- A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral HeterogeneityCell, 2019
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer LiabilitiesCell, 2015
- Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 InhibitionJournal of Medicinal Chemistry, 2015
- Expression of interferon receptors in pancreatic cancer: Identification of a novel prognostic factorSurgery, 2006